Serveur d'exploration Chloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Targeting the Erythrocytic and Liver Stages of Malaria Parasites with s‐Triazine‐Based Hybrids

Identifieur interne : 000F20 ( Main/Exploration ); précédent : 000F19; suivant : 000F21

Targeting the Erythrocytic and Liver Stages of Malaria Parasites with s‐Triazine‐Based Hybrids

Auteurs : Catarina A. B. Rodrigues [Portugal] ; Raquel F. M. Frade [Portugal] ; Inês S. Albuquerque [Portugal] ; Maria J. Perry [Portugal] ; Jiri Gut [États-Unis] ; Marta Machado [Portugal] ; Philip J. Rosenthal [États-Unis] ; Miguel Prudêncio [Portugal] ; Carlos A. M. Afonso [Portugal] ; Rui Moreira [Portugal]

Source :

RBID : ISTEX:B68D591C56E2EBD21703FB5D875CC686B37B66BC

Abstract

A diversity‐oriented library of s‐triazine‐based hybrids was screened for activity against the chloroquine‐resistant Plasmodium falciparum W2 strain. The most striking result was sub‐micromolar activity against cultured erythrocytic‐stage parasites of hybrid molecules containing one or two 8‐aminoquinoline moieties. These compounds were not clearly toxic to human cells. The most effective blood‐schizontocidal s‐triazine derivatives were then screened for activity against the liver stage of malaria parasites. The s‐triazine hybrid containing two 8‐aminoquinoline moieties and one chlorine atom emerged as the most potent against P. berghei liver‐stage infection, active in the low nanomolar region, combined with good metabolic stability in rat liver microsomes. These results indicate that s‐triazine‐8‐aminoquinoline‐based hybrids are excellent starting points for lead optimization as dual‐stage antimalarials.
Double‐edged sword to kill malaria parasites: s‐Triazine‐based hybrid compounds containing a primaquine moiety were found to be dual‐stage antiplasmodial agents. The two hybrids are highly potent against both the liver and blood stages of the parasite's life cycle and show excellent metabolic stability.

Url:
DOI: 10.1002/cmdc.201500011


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Targeting the Erythrocytic and Liver Stages of Malaria Parasites with s‐Triazine‐Based Hybrids</title>
<author>
<name sortKey="Rodrigues, Catarina A B" sort="Rodrigues, Catarina A B" uniqKey="Rodrigues C" first="Catarina A. B." last="Rodrigues">Catarina A. B. Rodrigues</name>
</author>
<author>
<name sortKey="Frade, Raquel F M" sort="Frade, Raquel F M" uniqKey="Frade R" first="Raquel F. M." last="Frade">Raquel F. M. Frade</name>
</author>
<author>
<name sortKey="Albuquerque, Ines S" sort="Albuquerque, Ines S" uniqKey="Albuquerque I" first="Inês S." last="Albuquerque">Inês S. Albuquerque</name>
</author>
<author>
<name sortKey="Perry, Maria J" sort="Perry, Maria J" uniqKey="Perry M" first="Maria J." last="Perry">Maria J. Perry</name>
</author>
<author>
<name sortKey="Gut, Jiri" sort="Gut, Jiri" uniqKey="Gut J" first="Jiri" last="Gut">Jiri Gut</name>
</author>
<author>
<name sortKey="Machado, Marta" sort="Machado, Marta" uniqKey="Machado M" first="Marta" last="Machado">Marta Machado</name>
</author>
<author>
<name sortKey="Rosenthal, Philip J" sort="Rosenthal, Philip J" uniqKey="Rosenthal P" first="Philip J." last="Rosenthal">Philip J. Rosenthal</name>
</author>
<author>
<name sortKey="Prudencio, Miguel" sort="Prudencio, Miguel" uniqKey="Prudencio M" first="Miguel" last="Prudêncio">Miguel Prudêncio</name>
</author>
<author>
<name sortKey="Afonso, Carlos A M" sort="Afonso, Carlos A M" uniqKey="Afonso C" first="Carlos A. M." last="Afonso">Carlos A. M. Afonso</name>
</author>
<author>
<name sortKey="Moreira, Rui" sort="Moreira, Rui" uniqKey="Moreira R" first="Rui" last="Moreira">Rui Moreira</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:B68D591C56E2EBD21703FB5D875CC686B37B66BC</idno>
<date when="2015" year="2015">2015</date>
<idno type="doi">10.1002/cmdc.201500011</idno>
<idno type="url">https://api.istex.fr/ark:/67375/WNG-PJJMR5WN-3/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001A35</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001A35</idno>
<idno type="wicri:Area/Istex/Curation">001A35</idno>
<idno type="wicri:Area/Istex/Checkpoint">000065</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000065</idno>
<idno type="wicri:doubleKey">1860-7179:2015:Rodrigues C:targeting:the:erythrocytic</idno>
<idno type="wicri:Area/Main/Merge">000F21</idno>
<idno type="wicri:Area/Main/Curation">000F20</idno>
<idno type="wicri:Area/Main/Exploration">000F20</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main">Targeting the Erythrocytic and Liver Stages of Malaria Parasites with s‐Triazine‐Based Hybrids</title>
<author>
<name sortKey="Rodrigues, Catarina A B" sort="Rodrigues, Catarina A B" uniqKey="Rodrigues C" first="Catarina A. B." last="Rodrigues">Catarina A. B. Rodrigues</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Portugal</country>
<wicri:regionArea>Instituto de Investigação do Medicamento (iMed.ULisboa), Faculdade de Farmácia, Universidade de Lisboa, Av. Prof. Gama Pinto</wicri:regionArea>
<wicri:noRegion>Av. Prof. Gama Pinto</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Frade, Raquel F M" sort="Frade, Raquel F M" uniqKey="Frade R" first="Raquel F. M." last="Frade">Raquel F. M. Frade</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Portugal</country>
<wicri:regionArea>Instituto de Investigação do Medicamento (iMed.ULisboa), Faculdade de Farmácia, Universidade de Lisboa, Av. Prof. Gama Pinto</wicri:regionArea>
<wicri:noRegion>Av. Prof. Gama Pinto</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Albuquerque, Ines S" sort="Albuquerque, Ines S" uniqKey="Albuquerque I" first="Inês S." last="Albuquerque">Inês S. Albuquerque</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Portugal</country>
<wicri:regionArea>Unidade de Malária, Instituto de Medicinal Molecular, Faculdade de Medicina, Universidade de Lisboa, Av. Prof. Egas Moniz, 1649‐028</wicri:regionArea>
<wicri:noRegion>1649‐028</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Perry, Maria J" sort="Perry, Maria J" uniqKey="Perry M" first="Maria J." last="Perry">Maria J. Perry</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Portugal</country>
<wicri:regionArea>Instituto de Investigação do Medicamento (iMed.ULisboa), Faculdade de Farmácia, Universidade de Lisboa, Av. Prof. Gama Pinto</wicri:regionArea>
<wicri:noRegion>Av. Prof. Gama Pinto</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Gut, Jiri" sort="Gut, Jiri" uniqKey="Gut J" first="Jiri" last="Gut">Jiri Gut</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Californie</region>
</placeName>
<wicri:cityArea>Department of Medicine, San Francisco General Hospital, University of California, San Francisco, Box 0811</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Machado, Marta" sort="Machado, Marta" uniqKey="Machado M" first="Marta" last="Machado">Marta Machado</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Portugal</country>
<wicri:regionArea>Unidade de Malária, Instituto de Medicinal Molecular, Faculdade de Medicina, Universidade de Lisboa, Av. Prof. Egas Moniz, 1649‐028</wicri:regionArea>
<wicri:noRegion>1649‐028</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Rosenthal, Philip J" sort="Rosenthal, Philip J" uniqKey="Rosenthal P" first="Philip J." last="Rosenthal">Philip J. Rosenthal</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Californie</region>
</placeName>
<wicri:cityArea>Department of Medicine, San Francisco General Hospital, University of California, San Francisco, Box 0811</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Prudencio, Miguel" sort="Prudencio, Miguel" uniqKey="Prudencio M" first="Miguel" last="Prudêncio">Miguel Prudêncio</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Portugal</country>
<wicri:regionArea>Unidade de Malária, Instituto de Medicinal Molecular, Faculdade de Medicina, Universidade de Lisboa, Av. Prof. Egas Moniz, 1649‐028</wicri:regionArea>
<wicri:noRegion>1649‐028</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Afonso, Carlos A M" sort="Afonso, Carlos A M" uniqKey="Afonso C" first="Carlos A. M." last="Afonso">Carlos A. M. Afonso</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Portugal</country>
<wicri:regionArea>Instituto de Investigação do Medicamento (iMed.ULisboa), Faculdade de Farmácia, Universidade de Lisboa, Av. Prof. Gama Pinto</wicri:regionArea>
<wicri:noRegion>Av. Prof. Gama Pinto</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<country wicri:rule="url">Portugal</country>
</affiliation>
<affiliation wicri:level="1">
<country xml:lang="fr">Portugal</country>
<wicri:regionArea>Correspondence address: Instituto de Investigação do Medicamento (iMed.ULisboa), Faculdade de Farmácia, Universidade de Lisboa, Av. Prof. Gama Pinto</wicri:regionArea>
<wicri:noRegion>Av. Prof. Gama Pinto</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Moreira, Rui" sort="Moreira, Rui" uniqKey="Moreira R" first="Rui" last="Moreira">Rui Moreira</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Portugal</country>
<wicri:regionArea>Instituto de Investigação do Medicamento (iMed.ULisboa), Faculdade de Farmácia, Universidade de Lisboa, Av. Prof. Gama Pinto</wicri:regionArea>
<wicri:noRegion>Av. Prof. Gama Pinto</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<country wicri:rule="url">Portugal</country>
</affiliation>
<affiliation wicri:level="1">
<country xml:lang="fr">Portugal</country>
<wicri:regionArea>Correspondence address: Instituto de Investigação do Medicamento (iMed.ULisboa), Faculdade de Farmácia, Universidade de Lisboa, Av. Prof. Gama Pinto</wicri:regionArea>
<wicri:noRegion>Av. Prof. Gama Pinto</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j" type="main">ChemMedChem</title>
<title level="j" type="alt">CHEMMEDCHEM</title>
<idno type="ISSN">1860-7179</idno>
<idno type="eISSN">1860-7187</idno>
<imprint>
<biblScope unit="vol">10</biblScope>
<biblScope unit="issue">5</biblScope>
<biblScope unit="page" from="883">883</biblScope>
<biblScope unit="page" to="890">890</biblScope>
<biblScope unit="page-count">8</biblScope>
<publisher>WILEY‐VCH Verlag</publisher>
<pubPlace>Weinheim</pubPlace>
<date type="published" when="2015-05">2015-05</date>
</imprint>
<idno type="ISSN">1860-7179</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">1860-7179</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">A diversity‐oriented library of s‐triazine‐based hybrids was screened for activity against the chloroquine‐resistant Plasmodium falciparum W2 strain. The most striking result was sub‐micromolar activity against cultured erythrocytic‐stage parasites of hybrid molecules containing one or two 8‐aminoquinoline moieties. These compounds were not clearly toxic to human cells. The most effective blood‐schizontocidal s‐triazine derivatives were then screened for activity against the liver stage of malaria parasites. The s‐triazine hybrid containing two 8‐aminoquinoline moieties and one chlorine atom emerged as the most potent against P. berghei liver‐stage infection, active in the low nanomolar region, combined with good metabolic stability in rat liver microsomes. These results indicate that s‐triazine‐8‐aminoquinoline‐based hybrids are excellent starting points for lead optimization as dual‐stage antimalarials.</div>
<div type="abstract" xml:lang="en">Double‐edged sword to kill malaria parasites: s‐Triazine‐based hybrid compounds containing a primaquine moiety were found to be dual‐stage antiplasmodial agents. The two hybrids are highly potent against both the liver and blood stages of the parasite's life cycle and show excellent metabolic stability.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Portugal</li>
<li>États-Unis</li>
</country>
<region>
<li>Californie</li>
</region>
</list>
<tree>
<country name="Portugal">
<noRegion>
<name sortKey="Rodrigues, Catarina A B" sort="Rodrigues, Catarina A B" uniqKey="Rodrigues C" first="Catarina A. B." last="Rodrigues">Catarina A. B. Rodrigues</name>
</noRegion>
<name sortKey="Afonso, Carlos A M" sort="Afonso, Carlos A M" uniqKey="Afonso C" first="Carlos A. M." last="Afonso">Carlos A. M. Afonso</name>
<name sortKey="Afonso, Carlos A M" sort="Afonso, Carlos A M" uniqKey="Afonso C" first="Carlos A. M." last="Afonso">Carlos A. M. Afonso</name>
<name sortKey="Afonso, Carlos A M" sort="Afonso, Carlos A M" uniqKey="Afonso C" first="Carlos A. M." last="Afonso">Carlos A. M. Afonso</name>
<name sortKey="Albuquerque, Ines S" sort="Albuquerque, Ines S" uniqKey="Albuquerque I" first="Inês S." last="Albuquerque">Inês S. Albuquerque</name>
<name sortKey="Frade, Raquel F M" sort="Frade, Raquel F M" uniqKey="Frade R" first="Raquel F. M." last="Frade">Raquel F. M. Frade</name>
<name sortKey="Machado, Marta" sort="Machado, Marta" uniqKey="Machado M" first="Marta" last="Machado">Marta Machado</name>
<name sortKey="Moreira, Rui" sort="Moreira, Rui" uniqKey="Moreira R" first="Rui" last="Moreira">Rui Moreira</name>
<name sortKey="Moreira, Rui" sort="Moreira, Rui" uniqKey="Moreira R" first="Rui" last="Moreira">Rui Moreira</name>
<name sortKey="Moreira, Rui" sort="Moreira, Rui" uniqKey="Moreira R" first="Rui" last="Moreira">Rui Moreira</name>
<name sortKey="Perry, Maria J" sort="Perry, Maria J" uniqKey="Perry M" first="Maria J." last="Perry">Maria J. Perry</name>
<name sortKey="Prudencio, Miguel" sort="Prudencio, Miguel" uniqKey="Prudencio M" first="Miguel" last="Prudêncio">Miguel Prudêncio</name>
</country>
<country name="États-Unis">
<region name="Californie">
<name sortKey="Gut, Jiri" sort="Gut, Jiri" uniqKey="Gut J" first="Jiri" last="Gut">Jiri Gut</name>
</region>
<name sortKey="Rosenthal, Philip J" sort="Rosenthal, Philip J" uniqKey="Rosenthal P" first="Philip J." last="Rosenthal">Philip J. Rosenthal</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000F20 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000F20 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:B68D591C56E2EBD21703FB5D875CC686B37B66BC
   |texte=   Targeting the Erythrocytic and Liver Stages of Malaria Parasites with s‐Triazine‐Based Hybrids
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021